회원가입 | 연락처 | 사이트맵 | English

      회사소개 | 리포트 | 커스텀 리서치 | 고객지원


로그인

카테고리

유/무선통신

전기/전자

디지털기기/미디어/방송

Information Technology

에너지

생명공학

화학/신소재

자동차

환경

일반소비재

마케팅/광고

금융

건설

교통/운송

소비자조사

방위/항공/우주

식음료

중공업

교육

기계

무역

스포츠/레저

해운/조선

패션

정부/정책

공예/귀금속

컴퍼니 프로파일

기타산업

 
현재위치 : HOME > 리포트 > 생명공학 > 제약
Investigation Report on China Imipenem and cilastatin sodium Market, 2010-2019
발행사 China Research and Intelligence

발행일 2015-06
분량 30 pages
서비스형태 Report
판매가격

인쇄하기

Description

Coming into being in the 1980s, penem is an unsatured β-lactam featuring broad spectrum, strong effect and low resistance rate. Actually it is the most potent antibiotic with the broadest antibacterial spectrum hitherto. And Imipenem cilastatin is one of the commercially available penem class.
Developed by Merck & Sharp Dohme (US) in 1979, imipenem and cilastatin sodium is the most famous one in imipenem cilastatin class. Its sales value around the world was USD 610 million in 2011 and USD 520 million in 2012, down 25.4% year-on-year. And imipenem and cilastatin sodium is used for the treatment of mixed infection caused by a variety of pathogens and aerobic or anaerobic bacteria as well as the early treatment before pathogens are identified.
Imipenem and cilastatin sodium develops fast after entering China with annual sales value rising from less than CNY 200 million in 2005 to CNY 595 million in 2014 and CAGR during this period reaching 15.6%. Currently, imipenem and cilastatin sodium in the Chinese market mainly come from the following companies: Merck & Sharp Dohme (US), United Laboratories, RANBAXY LABORATORIES LTD(ID) and Shenzhen Haibin Pharmaceutical Co., Ltd, among which Merck & Sharp Dohme (US) has the largest market share of 90% for sales value in 2014.
As the development programs and manufacturers of penem antibiotics increase, the market competition will become more and more severe in future. The market size of imipenem and cilastatin sodium is expected to keep expanding in the next few years in China.

Readers can get at least the following information from this report:

-market size of imipenem and cilastatin sodium in China
-competitive landscape of imipenem and cilastatin sodium in Chinese market
-price of imipenem and cilastatin sodium made by different enterprises in China
-market outlook of imipenem and cilastatin sodium in China

The author suggests the following groups of people purchase this report:

-manufacturers of anti-infective drugs
-investors/ research institutions interested in Chinese medicine market
-any interest in the Chinese medicine market, please contact CRI for customized survey service


회사소개 | 개인정보보호정책 | 이용약관 | 배송/결제안내 | 이용안내

서울시 강남구 논현동 210-1 삼원빌딩 | 회사명 : (주)엘앤에치
대표전화 : 02-554-0001 / 팩스 : 02-3444-5501 / 이메일 : sales@landh.co.kr
Copyright ⓒ 2008 LNH, Inc. All rights reserved.